Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06455202
Status:
RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-06-07
Brief Title:
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria CSU
Sponsor:
Celldex Therapeutics
Organization:
Celldex Therapeutics